| In-Hospital Length of stayab (95 % CI) | P-value |
---|---|---|
Age | 0.06 (0.05, 0.06) | <.0001 |
Sex | Â | <.0001 |
 Male | Ref |  |
 Female | −0.55 (−0.66,-0.45) |  |
Race/Ethnicity | Â | <.0001 |
 White | Ref |  |
 Black | 1.33 (1.16, 1.50) |  |
 Hispanic | 0.18 (−0.02, 0.39) |  |
 Other | 0.09 (−0.12, 0.30) |  |
Residential Income | <.0001 | |
 Q4-Highest | Ref |  |
 Q3 | 0.33 (0.18, 0.47) |  |
 Q2 | 0.37 (0.22, 0.52) |  |
 Q1-Lowest | 0.84 (0.68, 1.00) |  |
Stage | Â | <.0001 |
 Non-Metastatic | Ref |  |
 Metastatic | 1.76 (1.65, 1.87) |  |
Insurance Type | Â | <.0001 |
 Private | Ref |  |
 Medicare | 0.66 (0.51, 0.81) |  |
 Medicaid | 2.91 (2.66, 3.16) |  |
 Other | 1.72 (1.47, 1.96) |  |
Residential Region | <.0001 | |
 Large metro | Ref |  |
 Small metro | −0.36 (−0.48,-0.24) |  |
 Micropolitan | −0.71 (−0.88,-0.54) |  |
Comorbidities | Â | <.0001 |
 0 | Ref |  |
 1 | 1.52 (1.40, 1.65) |  |
 ≥ 2 | 3.01 (2.82, 3.21) |  |